Dana-Farber Cancer Institute shared a post on LinkedIn:
“Congratulations to Brian Wolpin and Andrew Aguirre recipients of the 2026 Mark Foundation-AACR-Lustgarten Foundation Early Detection Award for their research in KRAS-mutant pancreatic cancer.
This award is presented by The Mark Foundation for Cancer Research, American Association for Cancer Research, and The Lustgarten Foundation.”
Other articles featuring Dana-Farber Cancer Institute on OncoDaily.